Reduced Incidence of Severe Palmar-Plantar Erythrodysesthesia and Mucositis in a Prospective Multicenter Phase II Trial with Pegylated Liposomal Doxorubicin at 40 mg/m<sup>2</sup> Every 4 Weeks in Previously Treated Patients with Metastatic Breast Cancer

Salah-Eddin Al-Batran; Hans-Gerd Meerpohl; Gunter von Minckwitz; Akin Atmaca; Ulrich Kleeberg; Nadia Harbeck; Werner Lerbs; Detlef Hecker; Jalid Sehouli; Alexander Knuth; Elke Jager

doi:10.1159/000093005

Reduced Incidence of Severe Palmar-Plantar Erythrodysesthesia and Mucositis in a Prospective Multicenter Phase II Trial with Pegylated Liposomal Doxorubicin at 40 mg/m2 Every 4 Weeks in Previously Treated Patients with Metastatic Breast Cancer

Oncology ◽

10.1159/000093005 ◽

2006 ◽

Vol 70 (2) ◽

pp. 141-146 ◽

Cited By ~ 37

Author(s):

Salah-Eddin Al-Batran ◽

Hans-Gerd Meerpohl ◽

Gunter von Minckwitz ◽

Akin Atmaca ◽

Ulrich Kleeberg ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Pegylated Liposomal Doxorubicin ◽

Multicenter Phase ◽

Previously Treated Patients ◽

Previously Treated

Download Full-text

Pegylated liposomal doxorubicin and trastuzumab as 1st and 2nd line therapy in her2/neu positive metastatic breast cancer: a multicenter phase II trial

Breast Cancer Research and Treatment ◽

10.1007/s10549-008-0306-9 ◽

2009 ◽

Vol 117 (3) ◽

pp. 591-598 ◽

Cited By ~ 23

Author(s):

Elmar Stickeler ◽

Maximilian Klar ◽

Dirk Watermann ◽

Annette Geibel ◽

Martha Földi ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Pegylated Liposomal Doxorubicin ◽

Multicenter Phase ◽

Line Therapy

Download Full-text

The Clinical Benefit of Pegylated Liposomal Doxorubicin in Patients With Metastatic Breast Cancer Previously Treated With Conventional Anthracyclines: A Multicentre Phase II Trial

Breast Diseases A Year Book Quarterly ◽

10.1016/s1043-321x(07)80277-3 ◽

2007 ◽

Vol 18 (2) ◽

pp. 205

Author(s):

A.C. Wolff

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Clinical Benefit ◽

Liposomal Doxorubicin ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Pegylated Liposomal Doxorubicin ◽

Multicentre Phase ◽

Previously Treated

Download Full-text

The clinical benefit of pegylated liposomal doxorubicin in patients with metastatic breast cancer previously treated with conventional anthracyclines: a multicentre phase II trial

British Journal of Cancer ◽

10.1038/sj.bjc.6603158 ◽

2006 ◽

Vol 94 (11) ◽

pp. 1615-1620 ◽

Cited By ~ 49

Author(s):

S-E Al-Batran ◽

J Bischoff ◽

G von Minckwitz ◽

A Atmaca ◽

U Kleeberg ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Clinical Benefit ◽

Liposomal Doxorubicin ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Pegylated Liposomal Doxorubicin ◽

Multicentre Phase ◽

Previously Treated

Download Full-text

Impact of geriatric vulnerability parameters on pegylated liposomal doxorubicin (PLD) tolerance and outcome in elderly patients with metastatic breast cancer: Results of the DOGMES multicenter phase II GINECO trial.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.9122 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. 9122-9122 ◽

Cited By ~ 4

Author(s):

C. Falandry ◽

E. Brain ◽

M. Bonnefoy ◽

F. Mefti ◽

A. Savoye ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Elderly Patients ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Metastatic Breast ◽

Pegylated Liposomal Doxorubicin ◽

Multicenter Phase

Download Full-text

A multi-centre phase II trial of pegylated liposomal doxorubicin and trastuzumab in HER-2 over-expressing metastatic breast cancer (MBC)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.630 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 630-630 ◽

Cited By ~ 4

Author(s):

S. K. Chia ◽

M. Clemons ◽

L. A. Martin ◽

A. Rodgers ◽

K. Gelmon ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Pegylated Liposomal Doxorubicin ◽

Her 2

Download Full-text

A multi-centre phase II trial of pegylated liposomal doxorubicin and trastuzumab in HER-2 over-expressing metastatic breast cancer (MBC)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.630 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 630-630 ◽

Cited By ~ 2

Author(s):

S. K. Chia ◽

M. Clemons ◽

L. A. Martin ◽

A. Rodgers ◽

K. Gelmon ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Pegylated Liposomal Doxorubicin ◽

Her 2

Download Full-text

Myotax: A phase II trial of docetaxel plus non-pegylated liposomal doxorubicin as first-line therapy of metastatic breast cancer previously treated with adjuvant anthracyclines

European Journal of Cancer ◽

10.1016/j.ejca.2011.08.004 ◽

2011 ◽

Vol 47 (16) ◽

pp. 2396-2402 ◽

Cited By ~ 8

Author(s):

E. Curtit ◽

P. Nouyrigat ◽

N. Dohollou ◽

E. Levy ◽

A. Lortholary ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Liposomal Doxorubicin ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Pegylated Liposomal Doxorubicin ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Previously Treated

Download Full-text

Phase II Trial of Pegylated Liposomal Doxorubicin in Combination With Gemcitabine in Metastatic Breast Cancer Patients

American Journal of Clinical Oncology ◽

10.1097/coc.0b013e3182005783 ◽

2012 ◽

Vol 35 (1) ◽

pp. 18-21 ◽

Cited By ~ 11

Author(s):

Jean-Philippe Jacquin ◽

Cyrus Chargari ◽

Julie Thorin ◽

Dominique Mille ◽

Adrien Mélis ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Pegylated Liposomal Doxorubicin ◽

Breast Cancer Patients

Download Full-text

Non-pegylated liposomal doxorubicin and docetaxel in metastatic breast cancer: final results of a phase II trial

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-008-0887-3 ◽

2008 ◽

Vol 64 (2) ◽

pp. 401-406 ◽

Cited By ~ 8

Author(s):

Peter Schmid ◽

J. Krocker ◽

R. Kreienberg ◽

P. Klare ◽

K. Kittel ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Pegylated Liposomal Doxorubicin

Download Full-text

Oral metronomic administration of cyclophosphamide and vinorelbine in previously treated patients with metastatic breast cancer: Phase II trial.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.e11017 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. e11017-e11017

Author(s):

M. A. Pluma Jimenez ◽

M. Perez ◽

Y. L. Bautista Aragon ◽

R. Villalobos ◽

S. Rivera ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Previously Treated Patients ◽

Previously Treated ◽

Metronomic Administration

Download Full-text